Yukoh Nakazaki

1.7k citations

30 papers · 1.0k indexed · h-index 17

Co-authors: Glenn Dranoff Martín C. Mihm Masahisa Jinushi Daniel R. Carrasco Kenzaburo Tani Michael Dougan Shigetaka Asano Yoshikuni Tanioka
Topics: Immunotherapy and Immune Responses (15 papers)Virus-based gene therapy research (9 papers)Cancer Research and Treatments (5 papers)
Cited by: Immunology Oncology Developmental Neuroscience
Journals: Nature Journal of Clinical Investigation Blood
Partner nations: Japan United States Switzerland

In The Last Decade

Yukoh Nakazaki

30 papers receiving 1.0k citations

Peers

Countries citing papers authored by Yukoh Nakazaki

Since Specialization

Citations

This map shows the geographic impact of Yukoh Nakazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukoh Nakazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukoh Nakazaki more than expected).

Fields of papers citing papers by Yukoh Nakazaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukoh Nakazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukoh Nakazaki. The network helps show where Yukoh Nakazaki may publish in the future.

Co-authorship network of co-authors of Yukoh Nakazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Yukoh Nakazaki. A scholar is included among the top collaborators of Yukoh Nakazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukoh Nakazaki. Yukoh Nakazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analyses of Nivolumab Exposure and Clinical Safety Between 3-mg/kg Dosing and 240-mg Flat Dosing in Asian Patients with Advanced Renal Cell Carcinoma in the Real-World Clinical Setting 2020 ·Translational Oncology ·Renpei Kato,Daiki Ikarashi,(unknown),Shigekatsu Maekawa,Yoichiro Kato,Mitsugu Kanehira,Ryo Takata,(unknown),(unknown),(unknown),Yukoh Nakazaki,Wataru Obara	4
2	Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line 2020 ·Cellular and Molecular Immunology ·(unknown),(unknown),Kenjiro Asagoshi,Tomoaki Uchiki,(unknown),(unknown),Takashi Yabuki,(unknown),Naoki Takahashi,S Hashimoto,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Kunihiro Ohta,Yukoh Nakazaki	11
3	Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions 2014 ·Clinical Cancer Research ·Matthias Piesche,Vincent T. Ho,Haesook Kim,Yukoh Nakazaki,(unknown),Nasser K. Yaghi,Dmitriy Kolodin,(unknown),Peter Altevogt,Helena Kiefel,Edwin P. Alyea,Joseph H. Antin,Corey Cutler,John Koreth,Christine Canning,Jerome Ritz,Robert J. Soiffer,Glenn Dranoff	10
4	In vivo discovery of immunotherapy targets in the tumour microenvironment 2014 ·Nature ·Penghui Zhou,Donald R. Shaffer,Diana Alvarez Arias,Yukoh Nakazaki,Wouter Pos,Alexis J. Torres,Viviana Cremasco,Stephanie K. Dougan,Glenn S. Cowley,Kutlu G. Elpek,Jennifer L. Brogdon,John R. Lamb,Shannon J. Turley,Hidde L. Ploegh,David E. Root,J. Christopher Love,Glenn Dranoff,Nir Hacohen,Harvey Cantor,Kai W. Wucherpfennig	181
5	Active Immunotherapy Induces Antibody Responses That Target Tumor Angiogenesis 2010 ·Cancer Research ·Jonathan D. Schoenfeld,Masahisa Jinushi,Yukoh Nakazaki,Daniel Wiener,(unknown),Robert J. Soiffer,Donna Neuberg,Martín C. Mihm,F. Stephen Hodi,Glenn Dranoff	64
6	Milk Fat Globule EGF-8 Promotes Melanoma Progression through Coordinated Akt and Twist Signaling in the Tumor Microenvironment 2008 ·Cancer Research ·Masahisa Jinushi,Yukoh Nakazaki,Daniel R. Carrasco,Dobrin Draganov,Nicholas Souders,Matthew Johnson,Martín C. Mihm,Glenn Dranoff	95
7	TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model 2008 ·Cancer Immunology Immunotherapy ·Hiroyuki Inoue,Mutsunori Iga,Xin Meng,(unknown),Takafumi Nakamura,Ryo Kurita,Masaaki Nakayama,Yukoh Nakazaki,Koichi Takayama,Yoichi Nakanishi,Kenzaburo Tani	26
8	MFG-E8–mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF 2007 ·Journal of Clinical Investigation ·Masahisa Jinushi,Yukoh Nakazaki,Michael Dougan,Daniel R. Carrasco,Martín C. Mihm,Glenn Dranoff	161
9	Serial Analysis of Gene Expression in Progressing and Regressing Mouse Tumors Implicates the Involvement of RANTES and TARC in Antitumor Immune Responses 2006 ·Molecular Therapy ·Yukoh Nakazaki,Hidenori Hase,Hiroyuki Inoue,(unknown),(unknown),Gaku Sakaguchi,Ryo Kurita,Shigetaka Asano,Yusuke Nakamura,Kenzaburo Tani	17
10	p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate 2006 ·The Journal of Gene Medicine ·Reiko Kunisaki,Shuntaro Ikawa,Toyoki Maeda,Yukoh Nakazaki,Ryo Kurita,(unknown),(unknown),(unknown),Yasushi Soda,Tsuyoshi Tanabe,Taeko Dohi,Rie Kato,Yoji Ikawa,Shigetaka Asano,Kenzaburo Tani	18
11	Tal1/Scl Gene Transduction Using a Lentiviral Vector Stimulates Highly Efficient Hematopoietic Cell Differentiation from Common Marmoset ( Callithrix jacchus ) Embryonic Stem Cells 2006 ·Stem Cells ·Ryo Kurita,Erika Sasaki,(unknown),Takashi Hiroyama,Kashiya Takasugi,Hideyuki Imoto,Kiyoko Izawa,Dong Yan,Takao Hashiguchi,Yasushi Soda,Toyoki Maeda,Youko Suehiro,Yoshikuni Tanioka,Yukoh Nakazaki,Kenzaburo Tani	22
12	Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation 2004 ·Experimental Hematology ·Seok‐Goo Cho,(unknown),Yasushi Soda,Yukoh Nakazaki,Kiyoko Izawa,Kaoru Uchimaru,Satoshi Takahashi,Kenzaburo Tani,Arinobu Tojo,Shigetaka Asano	16
13	Clinically Mild, Atypical, and Aged Craniofacial Syndrome is Diagnosed as Crouzon Syndrome by Identification of a Point Mutation in the Fibroblast Growth Factor Receptor 2 Gene (FGFR2) 2004 ·Internal Medicine ·(unknown),Masamitsu Hatakenaka,Hiromi Muta,Masaaki Nakayama,Yukoh Nakazaki,(unknown),T. Suzuki,Kenzaburo Tani	8
14	Hematopoietic activity of common marmoset CD34 cells isolated by a novel monoclonal antibody MA24 2004 ·Experimental Hematology ·Kiyoko Izawa,Kenzaburo Tani,Yukoh Nakazaki,Hitoshi Hibino,Hajime Sugiyama,Akemi Koyanagi,Erika Sasaki,Chieko Nishioka,Hajime Ishii,Yasushi Soda,Hideo Yagita∥,Yoshikuni Tanioka,Arinobu Tojo,Shigetaka Asano	13
15	Haematopoietic progenitor cells from the common marmoset as targets of gene transduction by retroviral and adenoviral vectors 2001 ·European Journal Of Haematology ·Hitoshi Hibino,Kenzaburo Tani,Hajime Sugiyama,Shuzo Suzuki,(unknown),Kiyoko Izawa,Hidenori Hase,Yukoh Nakazaki,Tsuyoshi Tanabe,Jun Ooi,(unknown),Arinobu Tojo,(unknown),Yoshikuni Tanioka,Shigetaka Asano	7
16	MHC (Major Histocompatibility Complex)-DRB Genes and Polymorphisms in Common Marmoset 2000 ·Journal of Molecular Evolution ·(unknown),Kenzaburo Tani,Hajime Sugiyama,Hitoshi Hibino,Kiyoko Izawa,Tsuyoshi Tanabe,Yukoh Nakazaki,Hajime Ishii,Jun Ohashi,(unknown),(unknown),Arinobu Tojo,Yusuke Nakamura,Yoshikuni Tanioka,(unknown),(unknown)	13
17	TCR-Vβ repertoire analysis with RT-PCR was useful for the early detection of pulmonary relapsed T-cell lymphoma after autologous peripheral blood stem cell transplantation 2000 ·American Journal of Hematology ·Hidenori Hase,Kenzaburo Tani,Hitomi Nagayama,Kiyoshi Watari,Satoshi Takahashi,Jun Ooi,Naoki Shirafuji,Tohru Iseki,Yukoh Nakazaki,Takayuki Yamashita,Tetsuya Nakamura,Atsuko Masunaga,Taira Maekawa,Arinobu Tojo,Shigetaka Asano	1
18	The Common Marmoset as a Target Preclinical Primate Model for Cytokine and Gene Therapy Studies 1999 ·Blood ·Hitoshi Hibino,Kenzaburo Tani,Kenji Ikebuchi,(unknown),Hajime Sugiyama,Yukoh Nakazaki,Tsuyoshi Tanabe,Satoshi Takahashi,Arinobu Tojo,Shuzo Suzuki,Yoshikuni Tanioka,Yoshikazu Sugimoto,Tatsutoshi Nakahata,Shigetaka Asano	27
19	Vaccine effect of granulocyte–macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity 1998 ·Gene Therapy ·Yukoh Nakazaki,Kazutoshi Tani,(unknown),Hidetoshi Sumimoto,Hironori HIBINO,Tsuyoshi Tanabe,Ming‐Shiang Wu,Kazutaka Izawa,H. Häse,Satoshi Takahashi,Arinobu Tojo,Miyuki Azuma,Hirotaka Hamada,Shigeki Mori,S Asano	32
20	GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice 1997 ·International Journal of Cancer ·Hidetoshi Sumimoto,Kenzaburo Tani,Yukoh Nakazaki,Tsuyoshi Tanabe,Hitoshi Hibino,Hirofumi Hamada,Miyuki Azuma,Shigetaka Asano	24

About Yukoh Nakazaki

Yukoh Nakazaki is a scholar working on Immunology, Biotechnology and Genetics, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (15 papers), Virus-based gene therapy research (9 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Immunology (549 citations), Oncology (350 citations) and Developmental Neuroscience (27 citations). Yukoh Nakazaki has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Glenn Dranoff, Martín C. Mihm, Masahisa Jinushi, Daniel R. Carrasco, Kenzaburo Tani, Michael Dougan, Shigetaka Asano, Yoshikuni Tanioka, Ryo Kurita and Tsuyoshi Tanabe. Their work appears in journals such as Nature, Journal of Clinical Investigation and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact